QIAGEN is a medical - diagnostics & research company in the healthcare sector trading on NYSE, led by CEO Thierry L. Bernard, with a market cap of $8.3B.
Common questions about QIAGEN
QIAGEN is scheduled to report earnings for Q1 2026 on May 6, 2026 after market close. Analysts estimate revenue of $501.1M.
QIAGEN has approximately 5,900 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.